Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19

NCT04549922 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: ISIS 721744
DRUG: Normal Saline

Sponsor

Hospital do Coracao

Collaborators

[object Object]
[object Object]